Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.3 HKD | -1.39% |
|
+19.41% | 0.00% |
06-17 | Qyuns Therapeutics Releases Data from Phase 2 Trial for Prurigo Nodularis Drug | MT |
05-30 | Qyuns Therapeutics Enrolls First Subject in Phase 3 Trial of Skin Disease Drug | MT |
Business Summary
Number of employees: 331
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 222,071,600 | 29,342,600 ( 13.21 %) | 0 | 13.21 % |
Company contact information
Qyuns Therapeutics Co., Ltd.
Room 1310, Building 1 907 Yaocheng Avenue
225316, Taizhou
+
http://www.qyuns.net![address Qyuns Therapeutics Co., Ltd.(2509)](https://cdn.zonebourse.com/static/address/167442728.png)
Sector
1st Jan change | Capi. | |
---|---|---|
0.00% | 817M | |
+14.95% | 122B | |
+19.89% | 113B | |
+8.24% | 22.84B | |
-20.30% | 20.72B | |
-16.19% | 16.51B | |
-12.66% | 16.39B | |
-44.35% | 15.83B | |
+1.99% | 13.49B | |
+69.58% | 11.67B |
- Stock Market
- Equities
- 2509 Stock
- Company Qyuns Therapeutics Co., Ltd.